Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shohei Miyamoto

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Physical Review. E|June 17, 2017
Breakdown of the Stokes-Einstein relation in pure Lennard-Jones fluids: From gas to liquid via supercritical statesNorikazu Ohtori, Shohei Miyamoto, Yoshiki Ishii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Oncolytic coxsackievirus therapy as an immunostimulatorShohei Miyamoto, Miyako Sagara, Hiroshi Kohara, et al.
Anticancer Research|January 9, 2021
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3Miyako Sagara, Shohei Miyamoto, Shun Itoh, et al.
Organic Letters|January 15, 2014
Formal [4 + 1]-cycloaddition of homopropargyl alcohols to diazo dicarbonyl compounds giving substituted tetrahydrofuransFumiya Urabe, Shohei Miyamoto, Keisuke Takahashi, et al.
Scientific Reports|April 12, 2023
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancerAkira Sakamoto, Hiroyuki Inoue, Shohei Miyamoto, et al.
Journal of the Neurological Sciences|December 28, 2020
Width of the third ventricle as a highly-sensitive biomarker in chronic progressive neuro-Behçet's diseaseSunao Takahashi, Nobuo Sanjo, Shohei Miyamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2019
Photocontrollable mononegavirusesMaino Tahara, Yuto Takishima, Shohei Miyamoto, et al.
Molecular Therapy Oncolytics|November 17, 2016
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activityKaname Nosaki, Katsuyuki Hamada, Yuto Takashima, et al.
Journal of Pharmaceutical Health Care and Sciences|March 1, 2023
Influence of discontinuation of prophylactic antimicrobial agent for trabeculectomyYuuka Ushio, Hiroshi Yoshikawa, Tetsuya Murase, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2010
Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinomaXin Meng, Takafumi Nakamura, Toshihiko Okazaki, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Physical Review. E|June 17, 2017
Breakdown of the Stokes-Einstein relation in pure Lennard-Jones fluids: From gas to liquid via supercritical statesNorikazu Ohtori, Shohei Miyamoto, Yoshiki Ishii
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Oncolytic coxsackievirus therapy as an immunostimulatorShohei Miyamoto, Miyako Sagara, Hiroshi Kohara, et al.
Anticancer Research|January 9, 2021
Development of New Oncolytic Virotherapy Targeting Breast Cancer Using Coxsackievirus B3Miyako Sagara, Shohei Miyamoto, Shun Itoh, et al.
Organic Letters|January 15, 2014
Formal [4 + 1]-cycloaddition of homopropargyl alcohols to diazo dicarbonyl compounds giving substituted tetrahydrofuransFumiya Urabe, Shohei Miyamoto, Keisuke Takahashi, et al.
Scientific Reports|April 12, 2023
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancerAkira Sakamoto, Hiroyuki Inoue, Shohei Miyamoto, et al.
Journal of the Neurological Sciences|December 28, 2020
Width of the third ventricle as a highly-sensitive biomarker in chronic progressive neuro-Behçet's diseaseSunao Takahashi, Nobuo Sanjo, Shohei Miyamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2019
Photocontrollable mononegavirusesMaino Tahara, Yuto Takishima, Shohei Miyamoto, et al.
Molecular Therapy Oncolytics|November 17, 2016
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activityKaname Nosaki, Katsuyuki Hamada, Yuto Takashima, et al.
Journal of Pharmaceutical Health Care and Sciences|March 1, 2023
Influence of discontinuation of prophylactic antimicrobial agent for trabeculectomyYuuka Ushio, Hiroshi Yoshikawa, Tetsuya Murase, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2010
Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinomaXin Meng, Takafumi Nakamura, Toshihiko Okazaki, et al.
Pageof 2